Baker Bros. Advisors’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-6,195
| Closed | -$436K | – | 110 |
|
|
2022
Q4 | $436K | Hold |
6,195
| – | – | ﹤0.01% | 105 |
|
|
2022
Q3 | $533K | Hold |
6,195
| – | – | ﹤0.01% | 105 |
|
|
2022
Q2 | $512K | Sell |
6,195
-7,773
| -56% | -$642K | ﹤0.01% | 109 |
|
|
2022
Q1 | $2.32M | Hold |
13,968
| – | – | 0.01% | 99 |
|
|
2021
Q4 | $2.34M | Hold |
13,968
| – | – | 0.01% | 106 |
|
|
2021
Q3 | $1.21M | Hold |
13,968
| – | – | 0.01% | 116 |
|
|
2021
Q2 | $758K | Hold |
13,968
| – | – | ﹤0.01% | 118 |
|
|
2021
Q1 | $832K | Hold |
13,968
| – | – | ﹤0.01% | 121 |
|
|
2020
Q4 | $729K | Sell |
13,968
-43,528
| -76% | -$2.27M | ﹤0.01% | 121 |
|
|
2020
Q3 | $2.78M | Sell |
57,496
-2,504
| -4% | -$121K | 0.01% | 95 |
|
|
2020
Q2 | $3.11M | Buy |
+60,000
| New | +$3.11M | 0.01% | 86 |
|